Enacts provisions relating to insurance coverage of self-administered hormonal contraceptives
Impact
If enacted, SB1317 would have a significant impact on state laws regarding health insurance coverage, specifically addressing preventive care related to reproductive health. It would prohibit health insurance providers from imposing higher deductibles or co-payments on hormonal contraceptives compared to other similar healthcare services. This provision is designed to enhance the affordability and accessibility of contraceptive options for individuals covered by health plans within the state.
Summary
Senate Bill 1317 aims to amend Missouri's insurance laws by requiring health benefit plans to cover the dispensing of self-administered hormonal contraceptives. Under the proposed legislation, any insurance coverage offered in the state would need to reimburse healthcare providers or dispensing entities for contraceptives that are intended to last up to one year. This measure is seen as a step towards improving access to reproductive health services for women across Missouri.
Contention
While the bill is largely viewed as a positive move for reproductive rights advocates, there may be some contention surrounding its implications for insurers. Critics may argue that mandating coverage for specific health services could increase overall insurance costs. Supporters, however, contend that the long-term savings from reduced unintended pregnancies and associated healthcare costs would outweigh any initial increases in premium rates. The discourse around the bill suggests that there could be debates regarding the balance between enabling access to preventive care and managing the financial impact on insurance markets.
An Act to Require Health Insurance Coverage for Federally Approved Nonprescription Oral Hormonal Contraceptives and Nonprescription Emergency Contraceptives
A bill for an act relating to the ordering and dispensing of self-administered hormonal contraceptives by a pharmacist pursuant to statewide protocols.